Summary of Research: Brentuximab Vedotin and Nivolumab in Combination with Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin Lymphoma
Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke et autres
us, es, it, au (code pays fourni par la source)